Dental Practice Valuation Multiples in Wisconsin (2026)

Two Wisconsin general practices can throw off exactly the same profit, $181,740 a year, and sell $726,960 apart. Same chairs, same collections, same hygiene days. The spread comes from which pricing grid the buyer opens, and almost no owner finds out which grid applies to them until the letter of intent lands.

Here's our thesis, and plenty of owners will hate it: for the typical Wisconsin general practice, the EBITDA multiple is not a negotiable number. It's assigned to you by your size before anyone looks at your P&L, and the only reliable way to move it is to change the size of the practice, not the quality of the story you tell about it. If you're planning to argue your way from 4x to 6x on the strength of a loyal patient base and a good Google rating, we'd drop that plan now.

The Two 2026 Multiple Grids Don't Agree, and That's the Whole Game

There are two ways the market sizes a dental practice, and they produce different answers for the same building.

The first sorts by profit. Deal Prospectors puts single-location practices at 5x to 7x profit, mid-sized groups with $1M to $3M of profit at 7x to 9x, groups at $3M to $5M of profit at 9x to 11x, and $5M-plus platforms at 10x to 12x. Specialty practices run 10x to 14x. That same analysis calls 12x "about the ceiling for general dentistry," which is a polite way of saying the ceiling is somewhere you will never stand.

The second sorts by revenue. Dental Pitch Brokerage's 2026 guide puts practices under $1M in revenue at 3x to 5x EBITDA, $1M to $3M at 5x to 7x, $3M to $5M at 6x to 8x, and $5M-plus at 8x or better, with 20%-plus EBITDA margin as the bar for a premium price.

Read those side by side. A solo practice collecting $900,000 is a "single location" worth 5x to 7x on one grid and a sub-$1M practice worth 3x to 5x on the other. Both are honest descriptions of real transactions. The difference is that the higher band assumes a buyer who wants a standalone business, and the lower band assumes a buyer who wants a unit inside a group. Those buyers bid against different math, and in 2026 the second one shows up more often.

A multiple isn't a fact about your practice. It's a fact about who's allowed to bid on it.

Wisconsin's 2,300 Dentists Set the Floor Under Your Number

Every multiple gets applied to EBITDA, and EBITDA in dentistry is mostly an argument about what it costs to replace the owner in the chair. That cost is a labor market number, and in Wisconsin it's knowable.

The Bureau of Labor Statistics May 2023 wage estimates for Wisconsin count 2,300 general dentists in the state, with a median hourly wage of $82.14 and an annual mean wage of $179,260. At full-time hours, that median rate works out to roughly $170,851 a year.

That's the line a buyer draws through your discretionary earnings. Whatever you took out of the practice last year, the acquirer subtracts a market-rate clinician before calling anything EBITDA. Owners who produce $600,000 personally and pay themselves $400,000 do not get to keep the difference in the valuation. They get charged something in the range of that $179,260 mean, and sometimes more if the buyer thinks the replacement will need a production bonus to stay.

The 2,300 number matters in the other direction too. A thin dentist labor pool is why the replacement cost is real rather than theoretical, and it's why a practice that already runs on an associate's production, rather than the owner's, prices differently. You're not selling goodwill. You're selling a staffed operation that keeps running after you hand over the keys.

A $950,000 Practice in Waukesha, Priced Three Ways

Take a practice at the middle of the Wisconsin market. Collections of $950,000, five operatories, owner doing most of the dentistry, a hygienist and a half, one associate day a week.

Run overhead at 62% of collections before owner compensation. That's $589,000 of cost and $361,000 of owner's discretionary earnings.

Now subtract a replacement clinician at the Wisconsin mean of $179,260. EBITDA lands at $181,740, a margin of 19.1%.

That 19.1% is the problem. It's $8,260 of annual profit short of the 20% margin that Dental Pitch Brokerage names as the threshold for premium pricing.

Apply the revenue grid, under $1M at 3x to 5x, and the practice is worth $545,220 to $908,700. Apply the single-location profit grid at 5x to 7x and it's worth $908,700 to $1,272,180. The gap between the worst defensible price and the best is $726,960.

Now the part owners underweight. Suppose you spend a year taking $38,260 of permanent cost out: a renegotiated supply contract, one fewer front-desk seat after you move to digital forms, a lab change. EBITDA goes to $220,000, a 23.2% margin. At 5x, price goes from $908,700 to $1,100,000. You bought $191,300 of enterprise value with $38,260 of annual cost discipline.

Compare that to crossing a tier. Add an associate who produces $400,000, paid 35% of production, with 12% variable cost on that production and $20,000 of added staffing. Incremental EBITDA is $192,000. Total EBITDA is $373,740 on $1,350,000 of collections, a 27.7% margin, and the practice is now in the $1M to $3M revenue band at 5x to 7x. At the bottom of that band, 5x, the price is $1,868,700.

Same building. Roughly a million dollars of difference against the low-grid outcome. That is not a negotiation win. That's a different company.

What Most Owners Get Wrong: Treating the Multiple as the Variable

The specific mistake, and it's made most often by solo owners inside three years of retirement working from a CPA's valuation memo, is optimizing the multiple instead of the EBITDA and the tier.

It looks like this. The owner reads that practices trade at 5x to 7x, anchors on 7x, and spends the pre-sale year on things meant to justify the top of the band: new operatory chairs, a website refresh, a marketing push that lifts new patients but not margin. Then the offers come in at 4x, and they conclude the buyer is lowballing.

The buyer isn't lowballing. The buyer never had 7x available for a sub-$1M single location. The band was set the moment the revenue number was disclosed. Everything spent on the story was spent in the wrong place, and in the case of the new chairs it actively hurt, because capital spent in the final year shows up as cost without showing up as a durable earnings stream.

Our view: for a general practice under $1.5M in collections, stop tracking the multiple entirely and track two things, EBITDA margin and whether production survives your absence. Those are the only two levers that reach the price.

The Listing Pile Is Crowded at Exactly Your Size

Here's the supply picture, and it's uncomfortable if you own a mid-size general practice.

Across the 925 practices currently listed for sale in the Practice Market Index, our own dataset built from broker listings, median collections come in at $957,588, with the middle half between $650,000 and $1,500,000 (n=753). Narrow it to general practices and the median is $946,000, middle half $640,000 to $1,500,000 (n=644). Median operatory count is 5 (n=754), and median collections per operatory is $200,000, with the middle half running $146,875 to $268,708 (n=643).

These describe the asking side of the market, not practices generally. But that's the relevant side when you're the one selling. The listing pile is thick with five-operatory general practices collecting somewhere near a million dollars, which is to say your practice is not scarce. Scarcity is what pulls a buyer up a band, and at that size there isn't any.

The collections-per-operatory figure is the one we'd stare at. If you're running five chairs at $200,000 each, a buyer sees a practice using its physical capacity at roughly the middle of what's on offer. If you're running five chairs at $270,000 each, you've demonstrated the thing a group buyer actually pays for: throughput per square foot that they can replicate.

Why the Ownership Slide Isn't a Price Tailwind

The standard broker pitch in 2026 leans on consolidation. It's true that ownership is falling. ADA Health Policy Institute research from June 2025 puts 73% of U.S. dentists in ownership as of 2023, down from 85% in 2005. More dentists working for someone else means more acquisitions happened.

It does not automatically mean higher prices for you. A falling ownership rate also means a shrinking pool of individual dentists willing and able to buy a solo practice with an SBA loan, and individual buyers are the ones who pay the top of the single-location band because they're buying a job and a life, not a return on capital. Group buyers underwrite to a model. They have a number, and the number is not sentimental.

Supply of dentists is the other half. ADA HPI puts national dentist density at 60.0 dentists per 100,000 population in 2025, with 205,088 professionally active dentists. Where local supply is tight relative to patients, a practice is harder to replace by simply opening a new one, and acquirers pay for that. Where it isn't, a group can build instead of buy, and your price is capped by their construction budget.

What Actually Moves You Between Bands

Three things, in order of how much price they carry per dollar of effort:

• Permanent margin, not one-year margin. Get above 20% EBITDA after a market-rate clinician charge and hold it for two full years of tax returns. A cost cut in the year of sale gets discounted. A cost structure gets capitalized.
• Production that isn't yours. An associate covering meaningful production converts your practice from a job with equipment into a business. In a state with 2,300 general dentists, proving you can recruit and retain one is itself the asset.
• Chair throughput. Collections per operatory above the range in the listing data tells a buyer they can add hours without adding real estate. That's the cheapest growth a group can buy.

Notice what's missing: patient count, Google reviews, new equipment, and years in the community. Those keep the practice alive. They don't change the band.

Do This Before You Call a Broker

Pull last year's P&L and recalculate your profit with a $179,260 clinician charge subtracted, whatever you actually paid yourself. Divide that by collections and see whether you clear 20%. If you don't, you now have your pre-sale project and it's a cost project, not a marketing project. Give it 24 months before you list, because buyers price the trend, not the snapshot.

If you want to see where your practice lands against these bands before you hand your books to anyone with a commission attached, run your own numbers through our free valuation calculator. It applies the clinician charge the way an acquirer does and shows you which revenue tier you're actually in, which is usually the surprise.

What we're watching into 2027: whether the sub-$1M band holds at 3x to 5x or slides further as individual-buyer financing tightens. If SBA lending for solo acquisitions loosens meaningfully, the top of the single-location band comes back into reach and we'd revise this piece. Until then, assume the grid, not the pitch.